Chandan Healthcare IPO Details
The key details of Chandan Healthcare’s IPO are outlined below, covering all crucial aspects from price range to investment requirements and regulatory documents.
| IPO Size | ₹107.36 Cr |
| Price Range | ₹151 - ₹159 |
| Retail Quota | 35% |
| QIB Quota | 50% |
| NII Quota | 15% |
| Employee Discount | -- |
| Listing at | NSE |
| Minimum Quantity | 800 |
| Investment (cut-off price) | ₹1,27,200 |
| Pre IPO Promotor Holding | 69.96% |
| Post IPO Promotor Holding | Update soon |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Chandan Healthcare IPO Timelines
The IPO process for Chandan Healthcare includes key dates for participants to know. The timeline allows for strategic planning and participation, helping investors stay informed and engaged throughout the entire process.
10/02/2025
Start Date12/02/2025
End Date14/02/2025
Refund Initiation14/02/2025
Credit of Shares to Demat Ac17/02/2025
Listing DateChandan Healthcare IPO Lot Size
The Chandan Healthcare IPO has a fixed lot size of 800 shares, at an upper price band of ₹159 per share, requiring ₹127,200 per lot for retail investors. For HNI investors, the minimum application is 1,600 shares (2 lots) amounting to ₹254,400.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 800 | ₹1,27,200 |
| Retail Maximum | 1 | 800 | ₹1,27,200 |
| HNI Minimum | 2 | 1600 | ₹2,54,400 |
Chandan Healthcare IPO Subscription Status
The subscription status for Chandan Healthcare IPO shows market demand across different investor categories, providing valuable insights into the offering’s performance. You can track real-time subscription data below.
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| 7.58x | 18.85x | 2.44x | -- | 7.04x |
IPO Performance on Listing Day
On the listing day (February 17, 2025), Chandan Healthcare made a positive debut on the stock exchange. The stock opened at ₹165.10, delivering a modest premium of 3.8% over its issue price of ₹159. Throughout the trading session, the stock showed steady upward momentum, climbing to ₹173.35 while maintaining support at its opening price. The shares ended their first trading day at ₹173.35, securing a healthy gain of 9% over the issue price, reflecting optimistic market sentiment towards this healthcare company.
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹165.10 | ₹173.35 | ₹173.35 | ₹165.10 |
Chandan Healthcare IPO Company Financials
Chandan Healthcare reports robust performance in FY2024 with Total Income of ₹177.96 crores, managing expenses at ₹156.50 crores, and achieving a strong PAT (Profit After Tax) of ₹16.36 crores, demonstrating significant growth potential ahead of its public offering.
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2022 | ₹119.92 | ₹120.98 | -₹1.09 |
| FY 2022 | ₹137.03 | ₹132.02 | ₹3.59 |
| FY 2022 | ₹177.96 | ₹156.50 | ₹16.36 |
About Company
Chandan Healthcare Limited, founded in September 2003, operates diagnostic centers in North India with a focus on pathology and radiology services. As of August 31, 2024, the company manages a flagship laboratory, seven central laboratories, and twenty-six satellite centers, along with over 300 collection centers spread across more than 15 cities in Uttar Pradesh and over 10 in Uttarakhand. The company offers a broad array of diagnostic tests, including 1,118 tests spanning routine pathology, specialized tests like immunohistopathology and molecular pathology, and a variety of radiology services, such as x-rays, CT scans, and MRIs, supported by advanced equipment like 11 CT scanners and 4 MRI machines.
Chandan Diagnostics has been a leading player in India’s healthcare sector for 33 years, having served over 30 million patients and continuing to care for over 2.5 million annually. The company operates a vast network of more than 50 centers and 500 collection centers across Uttar Pradesh and Uttarakhand, offering a comprehensive range of diagnostic services, including cardiology, oncology, and neurology. Known for its commitment to international standards, Chandan Diagnostics employs advanced instrumentation and automation to ensure quick, accurate test results. Their flagship Chandan Speciality Lab in Lucknow is a state-of-the-art facility that sets new benchmarks in pathological services, solidifying the company’s leadership in diagnostic care.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 2003 | Healthcare | Amar Singh |
Know Before Investing
Chandan Healthcare IPO Strengths
- Chandan Healthcare is led by a promoter with over three decades of experience in the healthcare industry. This extensive background equips the company with valuable insights and expertise, enhancing its operational effectiveness and strategic decision-making.
- The company operates across multiple regions, including Uttar Pradesh, Delhi, and Uttarakhand, establishing a strong foothold in these markets. This geographic diversity helps mitigate risks associated with regional economic fluctuations.
- Chandan Healthcare is committed to leveraging advanced technology in its operations, which enhances the accuracy and efficiency of its diagnostic services. This focus on innovation positions the company as a leader in healthcare technology.
- With years of operation and a reputation for quality service, Chandan Healthcare has built strong brand recognition within its target markets. This recognition fosters customer loyalty and attracts new patients.
- The increasing awareness of health issues and the rising demand for quality healthcare services position Chandan Healthcare favorably within the expanding healthcare market.
- The healthcare sector is expected to grow significantly due to demographic changes and advancements in medical technology. Chandan Healthcare is well-positioned to capitalize on these trends as it expands its service offerings.
Chandan Healthcare IPO Risks
- Chandan Healthcare has a relatively short history as a public entity, which may create uncertainty regarding its long-term performance. Investors may find it challenging to assess the company’s sustainability and growth potential based on limited historical data.
- Chandan Healthcare operates in a working capital-intensive sector, with bank limit utilization averaging 85% over the last year. This high utilization indicates potential liquidity constraints that could impact operational flexibility and financial stability.
- The healthcare industry is sensitive to economic conditions. During economic downturns, patients may delay or forgo non-essential medical services, potentially impacting the company’s revenue and profitability.
- Operating in the healthcare sector involves strict regulatory compliance. Non-compliance with health regulations could lead to legal penalties, operational disruptions, and damage to the company’s reputation.
- A significant portion of revenue may come from a few major clients or contracts, increasing vulnerability to contract losses or changes in client relationships that could adversely affect revenue streams.
- The healthcare sector is highly competitive, with numerous players vying for market share. Increased competition can lead to pricing pressures and reduced margins, impacting profitability.
Swot Analysis for Chandan Healthcare IPO
Strengths
Established brand reputation, Comprehensive healthcare services, Skilled workforce
Weaknesses
Limited geographical presence, High operational costs, Dependency on specific markets
Opportunities
Growing healthcare demand, Expansion into telemedicine, Government health initiatives
Threats
Intense competition in healthcare sector, Regulatory challenges, Economic downturn impacts
Company Details
Chandan Healthcare Limited
Biotech Park, Sector G, Jankipuram, Kursi Road, Lucknow-226021
Phone: +91 8429024430
Email: secretarial@chandan.co.in
Website: https://www.chandandiagnostic.com/
IPO Registar Details
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: chl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
FAQs
The key objectives of Chandan Healthcare IPO are:
- Setting up a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh.
- Setting up a new Central Reference laboratory at Ayodhya, Uttar Pradesh
- Setting up a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh.
- General corporate purposes.
Unistone Capital Pvt Ltd is the book-running lead managers for the Chandan Healthcare IPO.